Actively Recruiting
Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound
Led by Fondation Ophtalmologique Adolphe de Rothschild · Updated on 2025-12-17
400
Participants Needed
5
Research Sites
204 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Abdominal aortic aneurysm (AAA) is a localized dilatation of a segment of the aorta artery in its abdominal portion. It affects 1.7% of men aged 65 years and older. In the high-risk population (male smokers aged 65-75 years), its prevalence is estimated to be between 2.8 and 9%. Mortality of ruptured AAAs is high (80% of deaths before hospitalization or perioperatively), whereas mortality of scheduled procedures for unruptured AAAs is less than 5%. AAA screening has been shown to significantly reduce the specific mortality rate in the medium and long term. The French National Authority for Health (HAS) recommends targeted screening for AAA by ultrasound at the radiologist. The target population is male smokers or former smokers aged 65 to 75 years, as well as all persons aged 50 to 75 years with a family history of AAA. Despite recommendations, the rate of access to targeted screening appears low. Ultrasound screening for AAA is a rapid, noninvasive, and reproducible test. It relies primarily on the measurement of the maximum diameter of the abdominal aorta in cross-section. It has been demonstrated that the learning of the ultrasound screening procedure for AAA is very fast and that the performance of non-radiologists trained in this procedure alone is similar to that of radiologists. In addition, new ultra-portable ultrasound devices, inexpensive and with validated performances have appeared on the market in the last few years, making it possible to equip general practitioners (GPs). We propose a simplified care pathway for AAA screening, by equipping GPs with an ultra-portable ultrasound scanner and by training them to perform the screening procedure, which will be performed in the office or at the patient's home, during a usual consultation of general medicine. Our hypothesis is that this new organization will allow better access to screening for the target population, at a lower cost, compared to the current screening method recommended by the HAS (referral of the patient to the radiologist).
CONDITIONS
Official Title
Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male
- If no family history of AAA: Age 65 to 75 years and current smoker or former smoker who quit less than 20 years ago
- If family history of AAA: Age 50 to 75 years
- Able to give consent to participate in the study
- Affiliated with or beneficiary of a social security plan
You will not qualify if you...
- Under legal protection measures
- Previous AAA screening within the last 5 years
- Unable to understand the study or give informed consent due to cognitive or communication issues
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Cabinet IPSO Brotteaux
Lyon, France, 69006
Actively Recruiting
2
Cabinet IPSO Saint Martin
Paris, France, 75003
Actively Recruiting
3
Cabinet IPSO Nation
Paris, France, 75011
Actively Recruiting
4
Cabinet IPSO Italie
Paris, France, 75013
Actively Recruiting
5
Cabinet IPSO Ourcq
Paris, France, 75019
Actively Recruiting
Research Team
A
Amélie YAVCHITZ, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here